Systematic rifampicin resistance errors with Xpert® MTB/RIF Ultra: implications for regulation of genotypic assays

Saved in:

Bibliographic Details
Published in:	The international journal of tuberculosis and lung disease Vol. 24; no. 12; pp. 1307 - 1311
Main Authors:	Omar, S. V., Hillemann, D., Pandey, S., Merker, M., Witt, A-K., Nadarajan, D., Barilar, I., Bainomugisa, A., Kelly, E. C., Diel, R., Vidanagama, D. S., Samarasinghe, A. I. P., Cader, M. R., Götsch, U., Lavu, E., Alabi, A., Schön, T., Coulter, C., Niemann, S., Maurer, F. P., Ismail, N. A., Köser, C. U., Ismail, F.
Format:	Journal Article
Language:	English
Published:	France International Union Against Tuberculosis and Lung Disease 01-12-2020 International Union against Tuberculosis and Lung Disease (IUATLD)
Subjects:	Antibiotics, Antitubercular - pharmacology Antibiotics, Antitubercular - therapeutic use Drug Resistance, Bacterial Humans Mycobacterium tuberculosis - genetics Rifampin Rifampin - pharmacology Sensitivity and Specificity
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	1027-3719(20201201)24:12L.1307;1- (R) Medicine - General SourceType-Other Sources-1 ObjectType-Article-2 content type line 63 ObjectType-Correspondence-1
ISSN:	1027-3719 1815-7920 1815-7920
DOI:	10.5588/ijtld.20.0396